Psychedelic Therapy Risk Analysis Tool: Difference between revisions

From BurnZero
mNo edit summary
mNo edit summary
 
Line 4: Line 4:


# Patient enters the site.
# Patient enters the site.
# Patient fills out PHQ-9 questionarie
# Patient fills out '''PHQ-9''' questionnaire to determine Depression Diagnosis. [https://www.mdcalc.com/calc/10043/hamilton-depression-rating-scale-ham-d Example].
# Patient fills out '''MGH-ATRQ''' questionnaire to determine Treatment Resistance. [https://www.nppsychnavigator.com/Clinical-Tools/Psychiatric-Scales/Antidepressant-Treatment-Response-Questionnaire-(A#:~:text=The%20Massachusetts%20General%20Hospital%20(MGH,major%20depressive%20disorder%20(MDD) Example]
# '''Borderline Personality Disorder''' - McLean Screening Instrument
# '''Significant suicide risk''' - Columbia-Suicide Severity Rating Scale (C-SSRS)

Latest revision as of 03:45, 30 October 2023

This is a work in progress. The idea is to create the foundations of a website which would haver the ability to serve specific psychometric tests which could analyse the risk of someone taking a psychedelic for the first time. The intention of this tool is to help people understand the risks involved and therefore reduce psychedelic anxiety syndrome by seeing how specific people fit into psychedelic therapy inclusion / exclusion criteria.

The website would work as follows:

  1. Patient enters the site.
  2. Patient fills out PHQ-9 questionnaire to determine Depression Diagnosis. Example.
  3. Patient fills out MGH-ATRQ questionnaire to determine Treatment Resistance. Example
  4. Borderline Personality Disorder - McLean Screening Instrument
  5. Significant suicide risk - Columbia-Suicide Severity Rating Scale (C-SSRS)

Share your opinion